Laboratory Report #37
Date
Collection Date: December 15, 2025
Report Date: December 20, 2025
Laboratory
Quest Diagnostics
Specialty Testing Platform:
Cardio IQ® Advanced Lipid Testing
Ordering Physician
Dr. Dale Yoo
Cardiology
Report Type
Advanced Cardiovascular Lipid Evaluation
This report was ordered to provide a more complete assessment of cardiovascular risk beyond a standard lipid panel.
Testing included:
- Total Cholesterol
- HDL Cholesterol
- Triglycerides
- LDL Cholesterol
- Non-HDL Cholesterol
- Cholesterol/HDL Ratio
- Advanced lipid interpretation
Original Report
PDF: Quest Diagnostics – Cardio IQ® Lipid Panel – December 15, 2025
One-Page Summary
Purpose of Testing
This advanced lipid evaluation was performed by Dr. Yoo to provide a more detailed assessment of cardiovascular risk. Because your health profile includes a unique lipid pattern—elevated LDL cholesterol combined with very high HDL cholesterol, very low triglycerides, and excellent inflammatory markers—advanced lipid testing provides important context beyond traditional cholesterol measurements.
This report is particularly valuable for the Health Inventory because it documents the cardiovascular questions being actively evaluated by your cardiologist.
Major Findings
1. Standard Lipid Profile
Results
| Test | Result | Interpretation |
|---|---|---|
| Total Cholesterol | 256 mg/dL | Elevated |
| LDL Cholesterol | 151 mg/dL | Elevated |
| HDL Cholesterol | 89 mg/dL | Excellent |
| Triglycerides | 60 mg/dL | Excellent |
| Non-HDL Cholesterol | 167 mg/dL | Elevated |
| Cholesterol/HDL Ratio | 2.9 | Favorable |
Interpretation
The lipid pattern remains consistent with your previous laboratory history.
The important features are:
Favorable Findings
✅ Very high HDL cholesterol
✅ Very low triglycerides
✅ Favorable cholesterol/HDL ratio
✅ Consistent pattern over multiple years
Area for Continued Evaluation
⚠ LDL cholesterol remains elevated.
The significance of LDL should be considered together with:
- ApoB
- LDL particle number
- Inflammatory markers
- Coronary history
- Blood pressure history
- Family history
- Overall cardiovascular risk
2. Longitudinal Lipid Pattern
The December 2025 Cardio IQ report confirms the trend seen since beginning the Health Inventory.
| Date | LDL | HDL | Triglycerides |
|---|---|---|---|
| November 2023 | 151 | 88 | 60 |
| June 2024 | 136 | 75 | 50 |
| November 2024 | 141 | 94 | 52 |
| December 2025 | 151 | 89 | 60 |
Interpretation
The pattern has remained remarkably stable:
- LDL has remained moderately elevated.
- HDL has remained exceptionally high.
- Triglycerides have remained very low.
This consistency suggests a persistent metabolic pattern rather than a temporary laboratory fluctuation.
3. Cardiovascular Significance
Why This Report Matters
Traditional lipid interpretation often focuses heavily on LDL cholesterol.
However, your overall cardiovascular profile includes additional favorable markers:
- Very low triglycerides
- High HDL cholesterol
- Low inflammatory markers
- Excellent glucose control
- Improved metabolic health after dietary changes
The purpose of advanced testing is to help determine how all these factors interact in assessing cardiovascular risk.
4. Relationship to Previous Health History
This report should be reviewed in the context of:
- History of hypertension
- History of atrial fibrillation
- Watchman implant
- Prior cardiovascular monitoring
- Family history of cardiovascular disease
- Previous inflammatory illness
Overall Interpretation
The December 15, 2025 Cardio IQ® Lipid Panel confirms a distinctive and stable lipid profile:
- LDL cholesterol remains elevated.
- HDL cholesterol remains exceptionally high.
- Triglycerides remain very low.
- The cholesterol/HDL ratio remains favorable.
The report does not provide a complete cardiovascular risk assessment by itself, but it provides important information for the ongoing discussion with Dr. Yoo regarding lipid management and prevention strategies.
Longitudinal Significance
This report contributes to:
- Cardiovascular Trend Analysis
- Lipid Trend Table
- Cardiologist Consultation Summary
- Section 3.2 — Hyperlipidemia
- Section 3.4 — Ascending Aortic Aneurysm Monitoring
- Section 3.3 — History of Atrial Fibrillation
Clinical Importance
⭐⭐⭐⭐⭐ Cardiology-Focused Assessment
This report is highly valuable because it documents the specific cardiovascular question being evaluated:
How should cardiovascular risk be interpreted when LDL cholesterol is elevated but HDL, triglycerides, inflammation, and metabolic markers are favorable?
This is precisely the type of question that requires longitudinal data rather than a single cholesterol number.
Key Findings
- Total Cholesterol: 256 mg/dL
- LDL Cholesterol: 151 mg/dL
- HDL Cholesterol: 89 mg/dL
- Triglycerides: 60 mg/dL
- Non-HDL Cholesterol: 167 mg/dL
- Cholesterol/HDL Ratio: 2.9
Related Reports
- Laboratory Report #35 — June 2025 Function Health / Quest Comprehensive Assessment
- Laboratory Report #36 — November 2025 Function Health Summary
- Laboratory Report #38 — December 30, 2025 Laboratory Evaluation
- Laboratory Report #39 — June 2026 Function Health Comprehensive Assessment
- Section 3.2 — Hyperlipidemia
- Physician Consultation Summary — Dr. Yoo
Navigation
Previous Report: November 2025 Function Health Summary
Next Report: December 30, 2025 Laboratory Evaluation
Return to Laboratory Library
Return to Health Inventory
Anchor My Faith 